Reprieve Cardiovascular
Milford, MA, United States · Healthcare, Health Care · 25 employees
Reprieve Cardiovascular Inc. is a startup focusing on developing an intelligent fluid management system for acute decompensated heart failure. Their technology aims to reduce the high rate of readmissions for heart failure patients by providing personalized diuretic dosing and fluid replacement.
Funding history
- Venture - Series Unknown — $30.9M — Jun 2025
- Venture - Series Unknown — $9.5M — Jan 2025
- Seed — $5.0M — Oct 2024
- Series A — $42.0M — Feb 2024
- Series A — $42.0M — Feb 2024
Recent signals
- Jun 05, 2025: Raised $30.9M in Venture - Series Unknown
- Jan 27, 2025: Raised $9.5M in Venture - Series Unknown
- Oct 02, 2024: Raised $5.0M in Seed
- Feb 21, 2024: Raised $42.0M in Series A
- Feb 20, 2024: Raised $42.0M in Series A
- Nov 20, 2023: Raised $12.1M in Venture - Series Unknown
- Aug 04, 2020: Raised $15.0M in Venture - Series Unknown
See plans & pricing → Track Reprieve Cardiovascular’s funding, hiring, and signals — with verified contacts — on Fundz.